← Back to home

IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY

Clinical trials for IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY explained in plain language.

Never miss a new study

Get alerted when new IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY trials appear

Sign up with your email to follow new studies for IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Common heart procedure poses kidney risk: can a diabetes pill be the shield?

Prevention Ongoing

This study is testing if a type of diabetes medication, called SGLT2 inhibitors, can prevent kidney damage in heart patients. The kidney damage can sometimes happen after patients receive a special dye during common heart procedures like angioplasty. Researchers will enroll 3600 …

Matched conditions: IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY

Sponsor: Shenyang Northern Hospital • Aim: Prevention

Last updated Apr 02, 2026 09:26 UTC

IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY

Get alerted when new IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY trials appear

Common heart procedure poses kidney risk: can a diabetes pill be the shield?